1f5k
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | [[Image:1f5k.png|left|200px]] | ||
- | |||
{{STRUCTURE_1f5k| PDB=1f5k | SCENE= }} | {{STRUCTURE_1f5k| PDB=1f5k | SCENE= }} | ||
- | |||
===UROKINASE PLASMINOGEN ACTIVATOR B-CHAIN-BENZAMIDINE COMPLEX=== | ===UROKINASE PLASMINOGEN ACTIVATOR B-CHAIN-BENZAMIDINE COMPLEX=== | ||
- | |||
{{ABSTRACT_PUBMED_10926521}} | {{ABSTRACT_PUBMED_10926521}} | ||
Line 14: | Line 10: | ||
==Reference== | ==Reference== | ||
- | <ref group="xtra">PMID:010926521</ref><references group="xtra"/> | + | <ref group="xtra">PMID:010926521</ref><references group="xtra"/><references/> |
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: U-plasminogen activator]] | [[Category: U-plasminogen activator]] |
Revision as of 06:57, 25 March 2013
Contents |
UROKINASE PLASMINOGEN ACTIVATOR B-CHAIN-BENZAMIDINE COMPLEX
Template:ABSTRACT PUBMED 10926521
About this Structure
1f5k is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Zeslawska E, Schweinitz A, Karcher A, Sondermann P, Sperl S, Sturzebecher J, Jacob U. Crystals of the urokinase type plasminogen activator variant beta(c)-uPAin complex with small molecule inhibitors open the way towards structure-based drug design. J Mol Biol. 2000 Aug 11;301(2):465-75. PMID:10926521 doi:http://dx.doi.org/10.1006/jmbi.2000.3966